Market News
Stay updated with the latest market trends, earnings, and economic indicators.

HealthQuad looking at deeper opportunities in new age healthcare with its Fund III
The early growth investor sees a wider and deeper opportunity across new age healthcare models, as demand and the pipeline of entrepreneurs building stronger, lasting businesses continues to grow
Torrent Pharmaceuticals Ltd eases for fifth straight session
Torrent Pharmaceuticals Ltd is quoting at Rs 4426.6, down 0.36% on the day as on 13:19 IST on the NSE. The stock jumped 39.91% in last one year as compared to a 2.73% slide in NIFTY and a 12.63% spurt in the Nifty Pharma index.
Wockhardt Ltd spurts 2.19%, rises for third straight session
Wockhardt Ltd is quoting at Rs 2067, up 2.19% on the day as on 12:49 IST on the NSE. The stock is up 22.5% in last one year as compared to a 2.73% gain in NIFTY and a 12.64% gain in the Nifty Pharma index.

Sensex Today | Stock Market LIVE Updates: Nifty, Sensex set for muted open; Anthem Biosciences in focus
Sensex Today | Stock Market LIVE Updates:Today is the weekly expiry of all BSE contracts. The recent phase for the market has been a good one, with the Nifty having recovered 1,000 points from last week's low of 23,070. A close above 24,000 is also a positive.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
Ipca Laboratories Ltd eases for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1575.6, down 0.47% on the day as on 13:19 IST on the NSE. The stock tumbled 15.63% in last one year as compared to a 4.2% slide in NIFTY and a 9.97% fall in the Nifty Pharma index.
Wockhardt Ltd eases for fifth straight session
Wockhardt Ltd is quoting at Rs 1874, down 0.72% on the day as on 13:19 IST on the NSE. The stock jumped 18.41% in last one year as compared to a 6.94% slide in NIFTY and a 10.46% spurt in the Nifty Pharma index.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
J B Chemicals & Pharmaceuticals Ltd soars 1.56%
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2206.6, up 1.56% on the day as on 12:49 IST on the NSE. The stock is up 32.31% in last one year as compared to a 7.57% spurt in NIFTY and a 10.6% spurt in the Nifty Pharma index.